MEIWU TECHNOLOGY CO LTD (WNW)

VGG9604C1150 - Common Stock

0.845  +0.01 (+1.14%)

After market: 0.8701 +0.03 (+2.97%)

Fundamental Rating

3

Taking everything into account, WNW scores 3 out of 10 in our fundamental rating. WNW was compared to 43 industry peers in the Consumer Staples Distribution & Retail industry. While WNW has a great health rating, there are worries on its profitability. WNW is valued expensive and it does not seem to be growing.



2

1. Profitability

1.1 Basic Checks

In the past year WNW has reported negative net income.
WNW had a positive operating cash flow in the past year.
In the past 5 years WNW always reported negative net income.
In the past 5 years WNW reported 4 times negative operating cash flow.

1.2 Ratios

WNW has a Return On Assets of -15.57%. This is amonst the worse of the industry: WNW underperforms 85.71% of its industry peers.
Looking at the Return On Equity, with a value of -23.35%, WNW is doing worse than 76.19% of the companies in the same industry.
WNW has a Return On Invested Capital of 5.13%. This is comparable to the rest of the industry: WNW outperforms 40.48% of its industry peers.
Industry RankSector Rank
ROA -15.57%
ROE -23.35%
ROIC 5.13%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

WNW has a Operating Margin of 9.08%. This is amongst the best in the industry. WNW outperforms 97.62% of its industry peers.
WNW has a Gross Margin of 16.96%. This is in the lower half of the industry: WNW underperforms 73.81% of its industry peers.
WNW's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 9.08%
PM (TTM) N/A
GM 16.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.77%
GM growth 5Y2.02%

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), WNW is destroying value.
There is no outstanding debt for WNW. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

Based on the Altman-Z score of 0.64, we must say that WNW is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.64, WNW is doing worse than 83.33% of the companies in the same industry.
WNW has a debt to FCF ratio of 0.11. This is a very positive value and a sign of high solvency as it would only need 0.11 years to pay back of all of its debts.
WNW has a better Debt to FCF ratio (0.11) than 92.86% of its industry peers.
WNW has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.01, WNW belongs to the top of the industry, outperforming 88.10% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.11
Altman-Z 0.64
ROIC/WACC0.9
WACC5.73%

2.3 Liquidity

WNW has a Current Ratio of 2.57. This indicates that WNW is financially healthy and has no problem in meeting its short term obligations.
WNW's Current ratio of 2.57 is amongst the best of the industry. WNW outperforms 88.10% of its industry peers.
WNW has a Quick Ratio of 2.54. This indicates that WNW is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.54, WNW belongs to the best of the industry, outperforming 92.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.57
Quick Ratio 2.54

2

3. Growth

3.1 Past

The earnings per share for WNW have decreased strongly by -2139.48% in the last year.
WNW shows a decrease in Revenue. In the last year, the revenue decreased by -0.02%.
Measured over the past years, WNW shows a very strong growth in Revenue. The Revenue has been growing by 59.01% on average per year.
EPS 1Y (TTM)-2139.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4884.39%
Revenue 1Y (TTM)-0.02%
Revenue growth 3Y-20.84%
Revenue growth 5Y59.01%
Sales Q2Q%-97%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

2

4. Valuation

4.1 Price/Earnings Ratio

WNW reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, WNW is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 0.68
EV/EBITDA -6.13

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for WNW!.
Industry RankSector Rank
Dividend Yield N/A

MEIWU TECHNOLOGY CO LTD

NASDAQ:WNW (11/25/2024, 8:00:02 PM)

After market: 0.8701 +0.03 (+2.97%)

0.845

+0.01 (+1.14%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.84M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.57%
ROE -23.35%
ROCE
ROIC
ROICexc
ROICexgc
OM 9.08%
PM (TTM) N/A
GM 16.96%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.57
Quick Ratio 2.54
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-2139.48%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-0.02%
Revenue growth 3Y-20.84%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y